Senate Approves Tighter Policing of Drug Makers

By: 

The senate passed new legislation that would empower the FDA to monitor the safety and efficacy of drugs already on the market.  Currently the FDA’s oversight is primarily limited primarily to pre-market approval, including the so-called clinical trial process.  Of particular interest is that under this plan the FDA would systematically track adverse drug reactions, the cause of up to 100,000 deaths annually in the United States.

Original Article

Topic: 

Add new comment

Filtered HTML

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd> <p> <div> <br> <sup> <sub>
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.